AUTONOMIX MEDICAL INC (AMIX) Stock Income Statement
USA - NASDAQ:AMIX - US05330T2050 - Common Stock
0.727 USD
0 (-0.45%)
| TTM (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 12.26M | 11.59M | 12.03M | 1.99M | 13.59M | |||
| Research and Development | 5.36M | 4.72M | 2.23M | 657.20K | 4.10K | |||
| Selling, General, and Administrative Expenses | 6.89M | 6.86M | 5.25M | 1.33M | 13.59M | |||
| Operating Income | -12.26M | -11.59M | -12.03M | -1.99M | -13.59M | |||
| Interest Income/Expense | 209.00K | 178.00K | 48.00K | null | 95.70K | |||
| Other Income/Expense | null | 0 | -3.44M | null | null | |||
| Non Recurring Items | null | null | null | null | 169.80K | |||
| Income Before Taxes | -12.05M | -11.41M | -15.43M | -1.99M | -13.33M | |||
| Income Tax | 0 | 0 | null | 0 | 0 | |||
| Net Income | -12.05M | -11.41M | -15.43M | -1.99M | -12.84M | |||
| EBITDA | -12.11M | -11.40M | -11.95M | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -6.1665 | -6.4594 | -16.3705 | -0.09 | -0.61 | |||
| Non GAAP EPS | -6.8100000000000005 | null | null | null | null | |||
| Statistics | ||||||||
All data in USD